Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (4), 587-590
- https://doi.org/10.1016/s0960-894x(01)00003-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2Nature Immunology, 2000
- Pyrrolidine Inhibitors of Human Cytosolic Phospholipase A2Journal of Medicinal Chemistry, 2000
- Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia CellsJournal of Biological Chemistry, 1999
- Molecular Cloning of Two New Human Paralogs of 85-kDa Cytosolic Phospholipase A2Journal of Biological Chemistry, 1999
- A Novel Calcium-independent Phospholipase A2, cPLA2-γ, That Is Prenylated and Contains Homology to cPLA2Journal of Biological Chemistry, 1998
- Role of cytosolic phospholipase A2 in allergic response and parturitionNature, 1997
- Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2Nature, 1997
- Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2Biochemistry, 1993
- Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.Proceedings of the National Academy of Sciences, 1990
- 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-l,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982